The Europe Sterility Testing Market should witness market growth of 9.8% CAGR during the forecast period (2023-2029).
In the sterilization, validation, and release testing phases of pharmaceutical manufacture, sterility testing is crucial. It plays a crucial role in many industries' sterilization validation processes, making it an important manufacturing procedure. It is a very tough process that needs to be well planned and carried out, which can help to weed out false positive results. False positive results are typically caused by lab contamination or staff error. Planned testing should be done in a spotless environment with little to no potential for error.
Additionally, this would guarantee that the viable microbial air & surface counts meet U.S. Pharmacopeia (USP) standards. The rules for good manufacturing practices restrict the use of sterility testing methodologies as an official test and the determination of appropriateness. It is necessary to provide suitable and accurate sterility test data to understand the benefits of sterility testing in the validation process and planning. Additionally, sterility testing is a laborious and artistic process that qualified personnel must carry out. Additionally, a thorough examination of environmental data and other elements, like sample collecting and sample procurement methods, is required during the investigative phase of a failed sterility test.
In Russia, each person spent an average of $140 on prescription drugs in 2018. Around $20.1 billion in pharmaceuticals were sold in Russia that same year, accounting for 1.2% of the country's GDP and 22.1% of all health expenditures. Both prescription and over the counter (OTC) medications fall within the pharmaceutical industry in Russia. In general, sales of prescription drugs dominated the pharmaceutical industry, which persisted in 2018 prescription drugs. The use of drugs containing gelatin will increase due to the developing healthcare industry and increased funding. The pharma industry in this region is expected to grow due to this expansion, which will increase demand for sterility testing.
The Germany market dominated the Europe Sterility Testing Market by Country in 2022; thereby, achieving a market value of $133.1 million by 2029. The UK market is exhibiting a CAGR of 8.8% during (2023-2029). Additionally, The France market would experience a CAGR of 10.6% during (2023-2029).
Based on Product, the market is segmented into Kits & Reagents, Instruments and Services. Based on Test Type, the market is segmented into Membrane Filtration, Direct Inoculation and Others. Based on Application, the market is segmented into Pharmaceuticals & Biologicals, Medical Devices and Others. Based on End-user, the market is segmented into Pharmaceutical Companies, Biotechnology Companies and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Charles River Laboratories International, Inc., SGS S.A., Merck KGaA, BioMérieux S.A., WuXi AppTec Co., Ltd., Sartorius AG, Samsung Biologics Co., Ltd. (Samsung Group), Nelson Laboratories, LLC (Sotera Health Company) and Pacific Biolabs, Inc.
In the sterilization, validation, and release testing phases of pharmaceutical manufacture, sterility testing is crucial. It plays a crucial role in many industries' sterilization validation processes, making it an important manufacturing procedure. It is a very tough process that needs to be well planned and carried out, which can help to weed out false positive results. False positive results are typically caused by lab contamination or staff error. Planned testing should be done in a spotless environment with little to no potential for error.
Additionally, this would guarantee that the viable microbial air & surface counts meet U.S. Pharmacopeia (USP) standards. The rules for good manufacturing practices restrict the use of sterility testing methodologies as an official test and the determination of appropriateness. It is necessary to provide suitable and accurate sterility test data to understand the benefits of sterility testing in the validation process and planning. Additionally, sterility testing is a laborious and artistic process that qualified personnel must carry out. Additionally, a thorough examination of environmental data and other elements, like sample collecting and sample procurement methods, is required during the investigative phase of a failed sterility test.
In Russia, each person spent an average of $140 on prescription drugs in 2018. Around $20.1 billion in pharmaceuticals were sold in Russia that same year, accounting for 1.2% of the country's GDP and 22.1% of all health expenditures. Both prescription and over the counter (OTC) medications fall within the pharmaceutical industry in Russia. In general, sales of prescription drugs dominated the pharmaceutical industry, which persisted in 2018 prescription drugs. The use of drugs containing gelatin will increase due to the developing healthcare industry and increased funding. The pharma industry in this region is expected to grow due to this expansion, which will increase demand for sterility testing.
The Germany market dominated the Europe Sterility Testing Market by Country in 2022; thereby, achieving a market value of $133.1 million by 2029. The UK market is exhibiting a CAGR of 8.8% during (2023-2029). Additionally, The France market would experience a CAGR of 10.6% during (2023-2029).
Based on Product, the market is segmented into Kits & Reagents, Instruments and Services. Based on Test Type, the market is segmented into Membrane Filtration, Direct Inoculation and Others. Based on Application, the market is segmented into Pharmaceuticals & Biologicals, Medical Devices and Others. Based on End-user, the market is segmented into Pharmaceutical Companies, Biotechnology Companies and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Charles River Laboratories International, Inc., SGS S.A., Merck KGaA, BioMérieux S.A., WuXi AppTec Co., Ltd., Sartorius AG, Samsung Biologics Co., Ltd. (Samsung Group), Nelson Laboratories, LLC (Sotera Health Company) and Pacific Biolabs, Inc.
Scope of the Study
By Product
- Kits & Reagents
- Instruments
- Services
By Test Type
- Membrane Filtration
- Direct Inoculation
- Others
By Application
- Pharmaceuticals & Biologicals
- Medical Devices
- Others
By End-user
- Pharmaceutical Companies
- Biotechnology Companies
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- Charles River Laboratories International, Inc.
- SGS S.A.
- Merck KGaA
- BioMérieux S.A.
- WuXi AppTec Co., Ltd.
- Sartorius AG
- Samsung Biologics Co., Ltd. (Samsung Group)
- Nelson Laboratories, LLC (Sotera Health Company)
- Pacific Biolabs, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Europe Sterility Testing Market by Product
Chapter 4. Europe Sterility Testing Market by Test Type
Chapter 5. Europe Sterility Testing Market by Application
Chapter 6. Europe Sterility Testing Market by End User
Chapter 7. Europe Sterility Testing Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Charles River Laboratories International, Inc.
- SGS S.A.
- Merck KGaA
- BioMérieux S.A.
- WuXi AppTec Co., Ltd.
- Sartorius AG
- Samsung Biologics Co., Ltd. (Samsung Group)
- Nelson Laboratories, LLC (Sotera Health Company)
- Pacific Biolabs, Inc.
Methodology
LOADING...
